Abstract

METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SITAGLIPTIN AND SIMVASTATIN IN PHARMACEUTICAL FORMULATION BY HPTLC

Malathi S* and Sivakumar T

ABSTRACT

This article gives a simple, rapid and accurate High performance thin layer chromatographic method for determination of Sitagliptin and Simvastatin in pharmaceutical formulation. Merck TLC aluminum sheets of silicagel G60 F254 with the thickness of 200 μm was used to carry out the separation. Ethyl acetate: toluene: methanol (6:2:2 v/v/v), was used as mobile phase. Analysis of the compounds was carried out by densitometry in the absorbance mode at 254 nm. The selected mobile phase gave the well defined peak at the Rf value of 0.6 +0.02 and 0.3+0.02 for sitagliptin and simvastatin respectively. Method was then validated for accuracy, linearity, precision, specificity, limit ofdetection (LOD) and limit of quantification (LOQ) as per ICH Guidelines. The linear regression analysis data for the calibration plots showed good linear relationship with the regression coefficient (r2) of 0.9999 and 0.9994 for the sitagliptin and simvastatin respectively, in the concentration range of 2-6 μg/spot,0.2-0.6 μg/spot respectively. The limit of detection and limit of quantification were 5, 20 ng /spot, 50,100 ng /spot respectively for sitagliptin and simvastatin. In conclusion, statistical analysis of data showed that the method is precise, selective and reproducible for estimation of both compounds. Hence the developed method can be applied in routine quality control analysis for identification and quantification of siatgliptin and simvastatin in pharmaceutical formulation.

Keywords: Sitagliptin, Simvastatin, HPTLC, Validation.